1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow CIDP - Chronic Inflammatory Demyelinating Polyneuropathy: new trials by email Literature Review of CIDP - Chronic Inflammatory Demyelinating Polyneuropathy trials Research Report on CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP empasiprubart, IVIg, empasiprubart-placebo - Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Phase 3 | Recruiting | argenx | 218 | 2025-08-22 | 2026-10-30 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Chronic Disease (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Peripheral Nervous System Diseases (1) · Polyneuropathies (1) · Polyradiculoneuropathy (1)
Immunoglobulins, Intravenous (1)
argenx (1)
Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · Colombia (1) · Czechia (1) · Estonia (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1)